MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.
home > drug information > Biaxin XL

Biaxin XL (clarithromycin extended-release tablets)


Company: Abbott Laboratories
Approval Status: Approved March 2000
Treatment for: Acute Bacterial Exacerbation of Chronic Bronchitis (AECB) and Acute Maxillary Sinusitis
Areas: Immunology/Infectious Diseases; Pulmonary/Respiratory Diseases

| General Information | Clinical Results | Side Effects | Additional Information |


General Information

Other Useful Resources

Biaxin XL Tablets is an extended-release form of the antibiotic Biaxin (clarithromycin). Biaxin XL is indicated for the treatment of:

  • Acute maxillary sinusitis (AMS) caused by
    • Influenzae
    • Catarrhalis
    • Pneumoniae
  • Acute bacterial exacerbation of chronic bronchitis (AECB) caused by
    • Influenzae
    • Parainfluenzae
    • Catarrhalis
    • Pneumoniae

[Biaxin Tablets (non extended-release) are also indicated for pharyngitis/tonsillitis, pneumonia, and uncomplicated skin and skin structure.]

Biaxin XL should be taken with food even though Biaxin Tablets and oral suspension may be taken with or without food.



< back to top

Clinical Results

94% of patients with Acute Exacerbation of Chronic Bronchitis (AECB) and 97% of patients with Acute Maxillary Sinusitis (AMS) taking Biaxin Tablets in clinical studies were cured or showed significant improvement.



< back to top

Side Effects

The most common side effects are:

  • Diarrhea (present in 6% of adults taking the medication)
  • Abnormal taste (6%)
  • Nausea (3%)

Discontinuation of treatment due to these adverse events occurred in fewer patients taking Biaxin XL than patients taking Biaxin Tablets.

Post-marketing spontaneously-reported adverse events included:

  • Various allergic reactions
  • Tooth discoloration
  • Alterations of sense of smell (often occurs in conjunction with abnormal taste)
  • Isolated reports of hearing loss (reversible)
  • Various transient central nervous system events (often resolved by discontinuing use of drug)
  • Infrequently reported hepatic dysfunction
  • Rare cases of hypoglycemia

Biaxin XL is contraindicated in patients with allergies to clarithromycin, erythromycin, or any macrolide antibiotic.
Concomitant administration of Biaxin with cisapride, pimozide, or terfenadine is contraindicated. Fatalities due to interactions between clarithromycin and these drugs have been reported.

Clarithromycin should not be administered to pregnant women.



< back to top

Additional Information

Visit the Abbott Laboratories web site, www.abbott.com, to learn more about Biaxin and about other products, research, and services provided by the company that developed this drug.



< back to top



The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.




free web search box


pda medical dictionary
pda software - $15

PDA Medical Dictionary

only $15

Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

>> Click here for more on the PDA Medical Dictionary <<




add to google

Add our searches to your Google homepage.

Add to Google

The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


Receive the latest medical news on your Google homepage.

Add to Google

The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





Privacy Policy   |    Disclaimer      

MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
MediLexicon International Ltd © 2009 All rights reserved.